Drug Profile
Chlorphenamine/codeine controlled release - Spriaso
Alternative Names: Chlorphenamine maleate/codeine phosphate extended release - Spriaso; Chlorpheniramine/codeine; Codeine/chlorpheniramine; LPCN 1084; Rinotuss12; Tuxarin ERLatest Information Update: 27 May 2021
Price :
$50
*
At a glance
- Originator Lipocine
- Developer Spriaso
- Class Antitussives; Morphinans; Opioid analgesics; Sedating antihistamines
- Mechanism of Action Histamine H1 receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Common cold; Cough